BioInvent’s BI-1206 Triplet Achieves 83% Response Rate in Refractory NHL with Improved Safety vs. SOC (EHA 2026)
BioInvent will host an in-person KOL lunch briefing (11:45 a.m. – 2:00 p.m. CEST / 5:45 – 8:00…
Browsing Tag